Oxygen-induced contraction of the ductus arteriosus (DA) involves a mitochondrial oxygen sensor, which signals pO 2 in the DA smooth muscle cell (DASMC) by increasing production of diffusible hydrogen peroxide (H 2 O 2 ). H 2 O 2 stimulates vasoconstriction by regulating ion channels and Rho kinase, leading to calcium influx and calcium sensitization. Because epidermal growth factor receptor (EGFR) signaling is also redox regulated and participates in oxygen sensing and vasoconstriction in other systems, we explored the role of the EGFR and its signaling cascade (p38 and c-Jun N-aminoterminal kinase (JNK)) in DA contraction. Experiments were performed in DA rings isolated from full-term New Zealand white rabbits and human DASMC. In human DASMCs, increasing pO 2 from hypoxia to normoxia (40 to 100 mmHg) significantly increased cytosolic calcium, p <0.01. This normoxic rise in intracellular calcium was mimicked by EGF and inhibited by EGFR siRNA. In DA rings, EGF caused contraction while the specific EGFR inhibitor (AG1478) and the tyrosine kinase inhibitors (genistein or tyrphostin A23) selectively attenuated oxygen-induced contraction (p<0.01). Conversely, orthovanadate, a tyrosine phosphatase inhibitor known to activate EGFR signaling, caused dose-dependent contraction of hypoxic DA and superimposed increases in oxygen caused minimal additional contraction. Anisomycin, an activator of EGFR's downstream kinases, p38 and JNK, caused DA contraction; conversely, oxygen-induced DA contraction was blocked by inhibitors of p38 mitogen-activated protein kinases (MAPK) (SB203580) or JNK (JNK inhibitor II). O 2 -induced phosphorylation of EGFR occurred within 5 min of increasing pO 2 and was inhibited by mitochondrial-targeted overexpression of catalase. AG1478 prevented the oxygen-induced p38 and JNK phosphorylation. In conclusion, O 2 -induced EGFR transactivation initiates p38/JNK-mediated increases in cytosolic calcium and contributes to DA contraction. The EGFR/p38/JNK pathway is regulated by mitochondrial redox signaling and is a promising therapeutic target for modulation of the patent ductus arteriosus.
Introduction
The ductus arteriosus (DA) plays an essential role in fetal life, diverting blood away from the unventilated lungs. At birth, the increase in arterial pO 2 causes DA contraction, thus diverting blood flow to the newly expanded lungs. Although vasodilatory effects of prostaglandin E2 and constrictor substances such as endothelin-1 [1] modulate this contraction, oxygen-induced contraction is an intrinsic property of DA smooth muscle cell (DASMC) [2, 3] . Persistent patent DA (PDA) is a common abnormality in the newborn, affecting 55 % of low-birth weight, premature infants [4] , resulting in heart failure and failure to thrive. Conversely, in some congenital heart disease conditions, it is critical to maintain DA patency to provide pulmonary or systemic blood flow for the newborn. Thus, understanding the mechanism by which O 2 constricts the DA is an important physiologic question and has practical translational applications in the treatment of PDA.
Rapid increases in pO 2 in DASMC are detected by a mitochondrial redox sensor. In response to a physiologic rise in pO 2 , the DASMC's mitochondria elaborate more reactive oxygen species (ROS), including H 2 O 2 [5, 6] . These ROS constitute a redox signal and initiate several vasoconstrictive events, including the following: (1) inhibition of the redoxsensitive, voltage-gated potassium channels, resulting in membrane depolarization and calcium entry through large conductance calcium (L-type) channels [3] ; (2) direct redoxmediated activation of L-type calcium channels [7] ; (3) release of calcium from the sarcoplasmic reticulum and activation of store-operated channels [8, 9] ; and (4) calcium-sensitization, primarily reflecting Rho kinase activation [8] [9] [10] .
Mitochondrial-derived H 2 O 2 production is dynamically modulated in proportion to pO 2 5 and is involved in initiating DASMC contraction [11] . H 2 O 2 is a diffusible signal that changes vascular tone by oxidizing sulfhydryl moieties in amino acids, such as cysteine, that regulate the conformation and function of enzymes and ion channels. By oxidizing catalytic cysteine residues, H 2 O 2 also inactivates protein tyrosine phosphatases, lipid phosphatases, and tumor suppressor phosphatase and tension homolog (PTEN), which modulates protein phosphorylation [12] . Tyrosine phosphorylation regulates many cellular responses, including contraction [13, 14] . In vivo, tyrosine phosphorylation is reversible and dynamic. The phosphorylation states are controlled by the coordinated action of protein tyrosine kinases (PTKs) and phosphatases (PTPs). Phosphorylation of tyrosine residues is involved in Ca 2+ influx, intracellular Ca 2+ release, and Ca 2+ sensitization of the contractile apparatus [15] . Clyman et al. have reported that the tyrosine kinase inhibitor, genistein (100 μM), inhibited both Ca 2+ -dependent and Ca
2+
-independent contraction in DA rings [9] ; however, the specific tyrosine kinase involved was not identified.
Epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. They are transmembrane proteins that are activated upon binding peptide growth factors and are involved in cellular transformation in cancer [16] . EGFR inhibitors, such as erlotinib, are used clinically to treat various cancers [17] . In the A431 cancer cell line, hypoxia activates EGFR signaling and induces epithelial to mesenchymal transition [18] . Hypoxia prolongs EGFR activation through a hypoxia-inducible factordependent deceleration of endocytosis-mediated EGFR deactivation [19] .
Although there is little information regarding the role of EGFR in vascular oxygen sensing, EGFR transactivation augments depolarization-induced Ca 2+ sensitization and vasoconstriction in chronically hypoxic pulmonary vascular SMC [20] . Moreover, EGFR transactivation is involved in H 2 O 2 , endothelin-1, and angiotensin II signaling [21] [22] [23] . EGFR mediates its effects by activation of a downstream kinase cascade that includes mitogen-activated protein kinases (MAPK), extracellular signal-regulated kinases (ERKs), c-Jun N-amino-terminal/stress-activated protein kinases (JNKs/SAPKs), and p38 MAPKs [21, 24, 25] .
We hypothesize that oxygen-induced increases in mitochondrial H 2 O 2 activate EGFR and contribute to oxygeninduced DA contraction. We investigated whether oxygen activates EGFR and used pharmacological probes to determine its downstream signaling cascade in rabbit DA rings and human DASMC. We report that H 2 O 2 -dependent EGFR activation raises cytosolic calcium and promotes DA contraction by increasing p38/JNK signaling. EGFR inhibition reduces constriction to oxygen but not KCl. We conclude that the phosphorylation status of EGFR is redox sensitive and is a key regulator of oxygen sensing in the DA.
Methods
All animal studies were approved by the Institutional Animal Care and Use Committee of the Minneapolis Veterans Affairs Medical Center and The University of Chicago Animal Care Committee and conform to current National Institutes of Health and American Physiology Society guidelines for the use and care of laboratory animals. Human DAs were obtained from infants with various forms of congenital heart disease at the time of surgical correction either at the University of Nebraska Children's Hospital or the University of Chicago, under protocols approved by the local institutional review board of both institutions. The demographics of these children, none of whom had PDA, have previously been described [5, 6] .
DA rings were isolated from pregnant New Zealand white rabbits at 30-31 days of gestation (term), as previously described [6, 8] . Briefly, the rabbits were anesthetized with ketamine (75 mg) and xylazine (20 mg) intramuscularly and pentobarbital (50 mg) intravenously. The fetal pups were delivered by cesarean section and a midline sternotomy was performed, before initiation of respiration. The heart, lungs, and great vessels were excised en bloc and placed in deoxygenated Earle's solution. The DA was carefully dissected free from adventitia under a dissecting microscope and then excised, excluding its attachments to the left pulmonary artery and descending thoracic aorta.
DA ring tension measurement
The isolated rabbit DA ring was connected to strain gauge transducers by two stainless steel wires. The ring was suspended in a 3-ml bath containing Earle's solution. The ring was equilibrated with a hypoxic gas mixture (0 % O 2 , 5 % CO 2 ; pO 2 = 22 ± 1 mmHg). The optimal resting tension (1,000 mg) was determined in hypoxic medium by measuring the maximum contractile response to KCl (60 mM) at varying basal tensions (200-2,000 mg). Indomethacin (3 μM) and L-NAME (100 μM) were present throughout all experiments. O 2 tension was recorded continuously with an M1-730 oxygen electrode (Microelectrode, Bedford, NH). A normoxic gas mixture (20 % O 2 , 5 % CO 2 , pO 2 =133±1 mmHg) was used to bubble the chamber solution creating normoxia. Data were recorded using an analog-digital computer system (MATLAB, ADInstruments Inc., Medford, MA).
Human DASMC culture
DASMCs from human neonates were isolated from freshly isolated human DA. The identity of the cells as DASMCs was confirmed by confirming positive immunostaining for SM α-actin but not von Willebrand's factor. A primary culture of DASMCs was established, and then the cells were harvested with trypsin, frozen in freezing media (10 % DMSO, 50 % FBS, and 40 % DMEM), and stored in liquid nitrogen for later use. DASMCs were grown in 100-mm culture dishes and used within the first five passages in culture. DASMCs were maintained in hypoxia (pO 2 40 mmHg, pH 7.35-7.45, pCO 2 30-40 mmHg) using an environmentally controlled Tri-Gas CO 2 incubator (Thermo Scientific) until the protocol called for exposure to normoxia.
Exposure of hypoxic human DASMC to acute normoxia
The experiment was performed in a chamber flushed with nitrogen. Inside the hypoxic chamber, two small glass containers (500 ml) were filled with Earle's solution (37°C). They were bubbled either with a hypoxic (0 % O 2 , 5 % CO 2 , pO 2 =28±2 mmHg) or normoxic (20 % O 2 , 5 % CO 2 , pO 2 =134±2 mmHg) gas mixture. DASMCs were immersed in the hypoxic solution for 30 min and then either maintained in hypoxia for 1, 3, 5, 10, or 20 min or quickly switched to the normoxia solution for 1, 3, 5, 10, or 20 min. At the end of the experiment, cells were flash frozen in liquid nitrogen and later lysed at 4°C under hypoxic conditions using the PhosphoSafe Extraction Reagent (Calbiochem, Billerica, MA) and a phosphatase inhibitor cocktail (Calbiochem, 1:100, Billerica, MA).
Real-time PCR
Total RNA was isolated from cultured cells or harvested tissues using the PureLink RNA Mini Kit (Invitrogen, Carlsbad, CA). Total RNA (0.5 μg) was reverse-transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Equal volumes of the resultant complementary DNA (cDNA) were used to evaluate the expression level of messenger RNAs (mRNAs) among treatments and controls by real-time PCR. The quantitative real-time PCR was performed on an Applied Biosystems 7900HT (Life Technologies, Grand Island, NY) as previously described [6] . The primers used were purchased from Applied Biosystems (Probe ID: EGFR: Hs01076087_m1; 18S: Hs99999901_s1).
siRNA for EGFR To achieve specific molecular knockdown of EGFR, we used several small interfering RNAs (siRNAs) as previously described [6] . siRNA for EGFR were the following: 5′GGCU GGUUAUGUCCUCAUUGCCCTC-3′, 5′GAGGGCAAUG AGGACAUAACCAGCCAC-3′, 5′-GGCGGGACAUAG UCAGCAGUGACTT-3′, and 5′-AAGUCACUGCUGAC UAUGUCCCGCCAC-3′. A scrambled siRNA control was used: 5′-CUUCCUCUCUUUCUCUCCCUUGUGA-3′. siRNA was purchased from Integrated DNA Technologies (Coralville, IA, USA).
Immunoblotting
Equal amounts of protein (20 μg) were subjected to SDS/ PAGE gradient gels (4-15 %), transferred to polyvinylidene difluoride membranes, blocked with 5 % (w/v) bovine serum albumin (BSA) in Tris-buffered saline with Tween 20 (TBST; 25 mM Tris-HCl, pH 7.4, 137 mM NaCl, and 0.1 % Tween 20) for 1 h, and incubated with primary antibodies in 5 % (w/v) BSA in TBST for 2 h at room temperature. The membranes were washed at least three times with TBST at 15-min intervals and then incubated with either mouse or rabbit or goat horseradish peroxidase-conjugated secondary antibody (1:2,000) for 1 h at room temperature. The membranes were developed with an enhanced chemiluminescence detection system according to the manufacturer's instructions. The following antibodies were obtained from Santa Cruz Biotechnology (Dallas, TX): rabbit anti-EGFR (sc-003, used for immunoblotting), mouse anti-L-caldesmon (1:200), and goat anti-phospho-caldesmon (tyr27, 1:400). The following antibodies were from Cell Signaling Technology, Inc. (Boston, MA): rabbit anti-p38 MAPK (1:1,000), rabbit anti-phospho-p38 MAPK (thr180/tyr182, 1:1,000), rabbit anti-SAPK/JNK (1:1,000), and rabbit antiphospho-SAPK/JNK (thr183/tyr185, 1:1,000). The following antibodies were from EMD (Gibbstown, NJ): ST1030 PhosphoDetect™ anti-Hsp27 (pSer82) mouse mAb (1:400) and mouse anti-Hsp27 (1:1,000). Mouse anti-caldesmon was from Sigma (1:1000).
Immunoprecipitation
A total of 400 μg of protein from human DASMCs was used for immunoprecipitation with mouse anti-EGFR monoclonal antibody (IgG2a, sc-120). Following gel electrophoresis, tyrosine-phosphorylated EGFR was detected by immunoblotting with monoclonal anti-phosphotyrosine (SC-508, Santa Cruz Biotechnology, Dallas, TX). Total EGFR was analyzed by re-probing of the same filter with anti-EGFR antibody (sc-003, 1:400, Santa Cruz Biotechnology, Dallas, TX).
Calcium imaging
Dual-excitation imaging with Fura-2 was used to measure the cytosolic Ca 2+ response to changes in oxygen tension in cultured human DASMC, as described [6, 26] . The human DASMCs were transferred to imaging dishes (Molecular Probes, Eugene, OR) and incubated in low-Ca 2+ Hanks' solution with the cell-permeable acetoxymethyl ester form of Fura-2 (0.1 μM) and Pluronic F-127 (0.8 μM) for 15 min at room temperature. The plates were then washed with HEPES buffer containing 1.5 mM Ca 2+ and incubated at room temperature for a further 20 min. The plates were then washed again and placed on the microscope stage. The drugs were added directly to the cells as a bolus by microinjection. All drugs were given in 10-μl volumes to reduce potential volume-induced artifacts. Saline injections of 10 μl had no effect on [Ca 2+ ] i . Changes in [Ca 2+ ] i were recorded in individual cells using a 340/380-nm MetaFluor filter-based imaging system (Universal Imaging, West Chester, PA) and a cooled charge-coupled device camera (Photometrics, Tucson, AZ).
Statistical analysis
Data are expressed as mean±SEM. In all figures, the SEM is indicated, although in some cases, it did not exceed the symbol size. Differences between groups were calculated using an unpaired Student's t test or simple ANOVA with post hoc analysis (Fisher's least significant difference test), as appropriate. A p<0.05 was considered statistically significant.
Results

Stimulatory G proteins (Gs) are involved in O 2 -induced DA contraction
EGFR is known to signal via G proteins [27] . Consequently, we assessed the effects of cholera toxin (a Gs inhibitor that is known to block the effects of EGFR [28] ) and pertussis toxin (a Gi inhibitor) on O 2 -induced contraction. Cholera toxin (1 mg/ml, 20-60-min incubation) attenuated the O 2 -induced DA contraction by~80 % (supplemental Fig. 1a, b) without affecting the hypoxic baseline tone or the contraction to KCl (60 mM), data not shown. Pertussis toxin (1 mg/ml, administered 20-60 min prior to increasing pO 2 ) had no effect on O 2 -induced DA contraction (supplemental Fig. 1c) . Because substantial published evidence suggests that endothelin may also contribute to DA contraction, we assessed the effects of endothelin receptor antagonists on DA contraction to oxygen [29] . BQ-123 (selective ET A receptor antagonist, 3 μM) and BQ-788 (selective ET B receptor antagonist, 3 μM) minimally reduced O 2 -induced contraction (supplemental Fig. 1d ), consistent with our previous findings [30] . These findings support the contention that oxygen-induced DA contraction involves Gs proteins and is not primarily dependent on endothelin-1.
Tyrosine kinases and tyrosine phosphatases are involved in O 2 -induced DA contraction Two structurally and functionally distinct tyrosine kinase inhibitors, genistein (Fig. 1a, c ) and tyrphostin A23 (Fig. 1b, c) , markedly reduced O 2 -induced DA contraction. Daidzein, an inactive control for genistein, had no effect on O 2 -induced DA contraction (Fig. 1c) . We next assessed whether tyrosine kinase inhibition targeted the upstream oxygen sensing or just the downstream effectors (activation of L-type calcium channels or store-operated channels (SOCs)). Genistein had no effect on 60 mM KCl-induced contraction (Fig. 1d) . This suggests that genistein affects an oxygen-sensing mechanism in the DA, rather than acting directly on downstream regulators of membrane potential, such as voltage-gated (Kv) channels, or L-type calcium channels (which together mediate KCl-induced contraction). Since SOCs have been implicated in DA contraction, we evaluated the possible effects of tyrosine kinase on SOCs by exposing DA rings to cyclopiazonic acid (CPA) in a calcium-free bath solution, to empty intracellular calcium and activate SOCs. A subsequent switch of the extracellular calcium from 0 to 2 mM (in the presence of nifedipine to block voltage-gated calcium channels) induced contraction, reflecting calcium entry through SOCs [8] . The finding that SOC-mediated DA contraction was also unaffected by genistein (Fig. 1e) indicates that the SOCs are not direct targets of tyrosine kinase in the DA.
The selective inhibitory effects of genistein on oxygeninduced contraction but not on contraction resulting from membrane potential depolarization or SOC-activation support the interpretation that tyrosine kinase activity contributes to the upstream mechanisms of O 2 -sensing mechanism in the DA.
Tyrosine phosphatase inhibition mimics O 2 -induced DA contraction
Since inhibition of tyrosine phosphorylation inhibited O 2 constriction, we next assessed whether increasing phosphorylation would cause DA constriction. Sodium orthovanadate, a nonspecific tyrosine phosphatase inhibitor, caused DA contraction and reduced subsequent O 2 -induced contraction (Fig. 2a-c) . When superimposed on oxygen-induced DA contraction, sodium orthovanadate causes little additional vasoconstriction (Fig. 2c) . The contraction which orthovanadate induced in hypoxic DA rings can be dose-dependently inhibited by the tyrosine kinase inhibitor, genistein (Fig. 2d) , consistent with genistein's effects on O 2 -induced contraction. In a further parallel, DA rings when exposed to 12-h O 2 and 2-h hypoxia (recovery) lost most (80 %) of the acute constrictor response to oxygen (as reported [31] ) and demonstrated a parallel impairment of contraction to sodium orthovanadate (~50 %). In contrast, the response to KCl was not affected in this experiment model [31] (data not shown). The parallel pharmacological profiles of orthovanadate, a putative tyrosine phosphatase inhibitor, and O 2 support the interpretation that tyrosine phosphorylation contributes to O 2 sensing in the DA.
EGFR transactivation is required for O 2 -mediated DA contraction
We next attempted to determine the identity of the G protein receptor-coupled tyrosine kinase that is primarily responsible for DA contraction. We compared effects of inhibitors of EGFR versus platelet-derived growth factor receptor (PDGFR) on DA tone. The EGFR inhibitor, AG1478 (30 μM), inhibited 80 % of the O 2 -induced DA contraction (Fig. 3a: representative trace; Fig. 3d : summary data), whereas pretreatment with the PDGFR inhibitor, AG1296 (30 μM), had no effect (Fig. 3d) . Moreover, AG1478 was selective for oxygen-induced vasoconstriction and did not significantly reduce KCl vasoconstriction ( Fig. 3a and supplemental Fig. 2 ). These results indicated that EGFR is the receptor-coupled tyrosine kinase that is primarily responsible for DA contraction and is regulated by the balance between tyrosine kinases and phosphatases.
Because EGFR is known to signal by means of p38 and JAK, we next explored the role of these kinases in DA contraction. AG490 (30 μM), an EGFR and JAK family tyrosine kinase inhibitor, completely inhibited O 2 -mediated DA contraction (Fig. 3b) . EGFR is also known to be phosphorylated and activated by Src [32] . The Src inhibitor PP2 (30 μM) also abolished O 2 -mediated DA contraction (Fig. 3c) . In contrast, the inactive Src control PP3 did not affect O 2 -induced DA contraction (Fig. 3d) . To determine whether the inhibitory effects of blocking EGFR were specific, we also evaluated the effects of a battery of inhibitors of other putative signaling pathways: LFM-A13 (a Bruton's Fig. 1 Tyrosine kinase inhibitors reduce the oxygen-induced DA contraction. Different tyrosine kinase inhibitors (genistein and tyrphostin) inhibited oxygeninduced DA contraction (a, b representative traces and c summary data). Daizein is negative control for genistein; n=4-7, **p<0.01. d Genistein had no effect on KCl-induced contraction, n=6. e Genistein had no effect on calcium switch from 0-to 2-mM-induced contraction in the presence of CPA and nifedipine, n=5 tyrosine kinase inhibitor), GM6001 (a matrix metalloproteinase inhibitor), and concanavalin A (an inhibitor of endocytotic processes). These did not affect the oxygen-induced DA contraction (data not shown).
p38 and JNK but not the ERK, PI 3 kinase pathways are involved in oxygen-induced DA contraction To further explore EGFR's downstream signal pathway, we studied the effect of anisomycin (30 μM), an activator of p38 and JNK. Anisomycin pretreatment markedly increased DA tension under hypoxic conditions (increasing tone to approximately 50 % of that achieved by O 2 -induced contraction, n= 5) and reduced subsequent oxygen-induced DA contraction (Fig. 4a, b) . The inhibition of p38 MAP kinase (SB202190 10 μM) or the inhibition of JNK (JNK inhibitor II, 10 μM) had, as predicted, the opposite effect, significantly attenuating O 2 -induced DA contraction (Fig. 4c) . In contrast, neither inhibition of ERK kinase with PD98059 (30 μM) nor inhibition of the PI3K pathway, with LY294002 (10 μM) or Fig. 2 Effects of a AG1478 (EGFR inhibitor, 30 μM AG1478 had no effect on KCl-induced contraction), b AG490 (EGFR and JAK family tyrosine kinase inhibitor), and c PP2 (Src family protein tyrosine kinases inhibitor) on oxygen-induced DA contraction. d Summary data and n number. PDGF inhibitor (AG1296) had no effect on O 2 -induced contraction. AICAR is an activator of AMP kinase Wortmannin (1 μM), altered O 2 -induced DA contraction (Fig. 4c) . These experiments indicate that p38 and JNK, but not the ERK and PI3K pathways, are involved in O 2 -induced DA contraction.
Proper attachment to the extracellular matrix is essential for cell survival [33] . Integrins are transmembrane heterodimeric adhesion receptors that mediate both cell-cell and cell-matrix interactions throughout the body [34] . Cooperation between integrins and EGFR plays an important role in the regulation of cell growth, differentiation, and survival, and it depends on c-Src kinase activities [35] . The integrin receptor ligand glyarg-gly-asp-ser-pro (GRGDSP) was used to test the possible effect of integrins on O 2 -induced DA contraction. Consistent with the proposed role of Src in the activation of EGFmediated DA contraction, GRGDSP (500 μM) and EGF (1 μg/ml) both caused significant DA contractions (36 or 50 % of the maximum O 2 -induced contraction, Fig. 5a ). As observed with oxygen, human EGF, GRGDSP, and orthovanadate increased cytosolic calcium in human DASMCs (Fig. 5b, c) . In addition, EGFR siRNA (but not the scrambled control) markedly reduced EGFR mRNA and attenuated O 2 -induced increases in cytosolic calcium in DASMC. The O 2 -induced Fura-2 ratio change was significantly decreased from +0.11±0.01 (scrambled siRNA, n=57) to +0.03±0.0 (siEGFR, n=87); p<0.01 (supplemental Fig. 3 ). These data support the concept that Src-mediated activation of EGFR might contribute to O 2 -induced DA contraction.
Mitochondria-derived H 2 O 2 mediates O 2 -induced EGFR phosphorylation in human DASMC
We next studied the acute effect of O 2 on EGFR in human DASMCs. Using immunoprecipitation with anti-EGFR, we found that acute oxygen exposure for as little as 3 min significantly increased EGFR tyrosine phosphorylation (Fig. 6a) . By immunostaining technique, we found that EGFR tyrosine Fig. 4 p38 and JNK but residue Y1173 is rapidly phosphorylated by acute (15 min) oxygen exposure in human DASMCs (Fig. 6b, c) .
Previous studies had shown that augmenting intracellular catalase attenuates O 2 sensing in DASMC [36] . We further studied the compartmental specificity of the signaling H 2 O 2 effect on EGFR phosphorylation by infecting DASMC with the adenoviral vector containing a mitochondrial-targeted catalase gene (Ad-mitoCAT [6] ). O 2 -induced EGFR tyrosine Y1173 residue phosphorylation was significantly inhibited by transfection of DASMC with Ad-mitoCAT, versus Adempty (each at 100 MOI for 96 h) (Fig. 6b, c) . By qRT-PCR, we also found that EGFR mRNA was also significantly increased in cultured human DASMCs exposed to increased pO 2 for 1 to 72 h (Fig. 6d) . These findings are consistent with the interpretation that mitochondrial-derived hydrogen peroxide is essential for the oxygen-induced activation (phosphorylation) of EGFR.
Acute O 2 exposure causes EGFR-dependent p38 and JNK phosphorylation in human DASMCs O 2 exposure caused time-dependent phosphorylation of p38 (at thr180/tyr182) and JNK (at thr183/tyr185) in cultured human DASMCs, with a peak response at 3 to 5 min (Fig. 7a, b) . The O 2 -induced phosphorylation of p38 and JNK was completely attenuated by the EGFR inhibitor, AG1478 (Fig. 7c, d ), which suggests that O 2 -induced EGFR transactivation is the upstream signal of p38 and JNK phosphorylation (Fig. 8) .
Discussion
It is widely accepted that receptor tyrosine kinases play an important part in vasoconstriction elicited in response to activation of G protein-coupled receptors. In this study, we demonstrate that tyrosine kinases play a key role in O 2 -induced DA contraction (Figs. 1 and 2) . Activation of G proteincoupled receptors (GPCRs), particularly EGFR, is involved in DA O 2 sensing. We demonstrate that O 2 causes EGFR transactivation and initiates signaling through a p38/JNK cascade. This signaling pathway requires mitochondrial-derived H 2 O 2 . The EGFR pathway increases calcium influx and release, resulting in DA contraction (Fig. 8) .
Mitochondrial-derived H 2 O 2 -mediated EGFR transactivation is involved in O 2 -induced DA contraction EGF (1 μg/ml) causes about 50 % of the maximal O 2 -induced contraction in rabbit DA rings (Fig. 5a ) and stimulates a robust increase in intracellular calcium (~700 nM) in human DASMCs (Fig. 5b, c) . Conversely, the EGFR inhibitor, AG1478, abolished 80 % of the O 2 -induced DA contraction (Fig. 3a, d ), whereas the PDGFR inhibitor, AG1296, had no effect (Fig. 3d) . The EGFR inhibitor effect on O 2 -induced contraction seems specific because it had no significant effect on KCl-induced contraction (Fig. 3a, supplemental Fig. 2a) . These data indicate that EGFR transactivation is required for O 2 -mediated DA contraction.
The mitochondrial electron transport chain has been proposed as the DA's O 2 sensor for more than a decade [2, 37, 38] . Inhibitors of either ETC complex I or complex III can fully and selectively abolish and relax O 2 -induced DA contraction [2, 38] . Recently, we have found that an early step in mitochondrial-based O 2 sensing involves a change in mitochondrial structure. Physiologic increases in O 2 level cause mitochondrial fission. Within 5 min of normoxia, DASMC mitochondria fragment by means of an actively regulated process (fission). Fission is required for both the pO 2 -induced increases in H 2 O 2 and vasoconstriction [6] . Inhibition of either mitochondrial fission or mitochondria-derived H 2 O 2 production selectively prevents O 2 -induced DA contraction without Fig. 7 The O 2 -induced phosphorylation of p38 and JNK is completely reduced by the EGFR inhibitor, AG1478. p38 and JNK were phosphorylated in cultured human DASMCs within 5 min of normoxia (a, b) and can be significantly inhibited by EGFR inhibitor, AG1478 (c, d) (n=3-6) Fig. 8 [39] . Approximately two thirds of the calcium required for O 2 -induced contraction enter the DASMC via the L-type calcium channel [3] . The O 2 -sensitive Kv channels (Kv1.5 and Kv2.1) in human DA are inhibited by O 2 and cause calcium entry through L-type calcium channels [30] . (2) O 2 causes calcium release from the sarcoplasmic reticulum in DASMC and further induces calcium entry through store-operated channels [8, 40] . (3) Rho kinase-related calcium sensitization changes, which permits prolonged interaction of actin and myosin at any given Ca 2+ level [8, 10, 40] . DA contraction ultimately reflects the aggregate effect of increased cytosolic calcium in the cytosol and calcium sensitization.
EGFR regulates the intracellular effects of ligands such as EGF and transforming growth factor-α (TGFα). Upon stimulation, EGFR undergoes a transition from an inactive monomeric form to an active homodimer and stimulates its intrinsic intracellular protein tyrosine kinase activity. Several tyrosine (Y) residues in the C-terminal domain of EGFR, including Y1173, can be autophosphorylated. EGFR has also been reported to be an H 2 O 2 -sensitive target [41] . The mechanism involves a direct protein sulfenylation modification of EGFR by H 2 O 2 at a critical active site cysteine (Cys797), which enhances its tyrosine kinase activity [41] . In our study, the EGFR tyrosine residue Y1173 was rapidly phosphorylated by acute (3-15 min) O 2 exposure (Fig. 6a, b) . By using mitochondria-specific overexpression of catalase with AdmitoCAT in cultured DASMCs, we proved that the mitochondria-specific H 2 O 2 is a very important initiator of O 2 -induced EGFR phosphorylation (Fig. 6b) . The significant mRNA upregulation of EGFR after 1 h of O 2 exposure in cultured human DASMCs (Fig. 6d) suggests that EGFR is O 2 -sensitive at the transcriptional as well as the posttranslational level. To confirm molecular specificity, we supplemented the findings using pharmacologic inhibitors of EGFR with siRNA targeting of EGFR in cultured human DASMC. The inhibitory effect of siRNA EGFR on the calcium increases caused by oxygen suggests that EGFR plays an important role on O 2 sensing (Fig. 5e) . Thus, EGFR is sensitive to acute oxygen change and can be quickly transactivated by mitochondriaspecific H 2 O 2 .
EGFR transactivation can be induced by many stimuli including reactive oxygen species and occurs through several pathways [22, [42] [43] [44] . Tseng et al. reported that NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes [45] . Zhuang et al. reported that H 2 O 2 -induced EGFR transactivation is dependent on the activation of Src, whereas chelation of intracellular Ca 2+ or inhibition of conventional and novel PKC had no effect on H 2 O 2 -induced EGFR transactivation in renal proximal tubular cells [21] . They also found that H 2 O 2 induced the phosphorylation of Src tyrosine 416, which is required for Src activity, and the phosphorylation of EGFR tyrosine 845, the Src-mediated phosphorylation site. Furthermore, the inhibition of EGFR did not interfere with H 2 O 2 -induced Src activation. These data support the concept that Src acts upstream of the EGFR in H 2 O 2 -treated cells [21] . Our data that Src inhibitor PP2 significantly inhibited O 2 -induced DA contraction, whereas its inactive control PP3 had no effect, is consistent with this concept (Fig. 3c, d ).
Both PTKs and PTPs are sensitive to reactive oxygen species, redox status, and oxygen level changes [46] [47] [48] . Reversible oxidation of the active site cysteine residue has recently been identified as a general mechanism for the regulation of PTPs. Transient oxidation of thiols in PTPs leads to their inactivation by the formation of either an intermolecular S-S bridge or a sulfenyl-amide bond. Conversely, oxidation of PTKs leads to their activation, either by direct SH modification or, indirectly, by concomitant inhibition of PTPs that leads to sustained phosphorylation of PTKs [49] [50] [51] . By using a modified cysteinyl-labeling assay, we found that PTP activity is decreased after 5-10 min of O 2 exposure in human DASMCs (supplemental Fig. 4 ). This may contribute to the overall increase in activity of tyrosine kinases, including EGFR, p38, and JNK (Figs. 6a-c and 7 ).
p38 MAPK and JNK are EGFR transactivation downstream targets
The MAPK family is the main downstream target of EGFR transactivation [52, 53] . The family includes three subfamilies with multiple members: the ERKs, the JNKs/SAPKs, and the p38 MAPKs. ERK1/2 is typically stimulated by growth factors acting via a tyrosine kinase receptor and is involved in the regulation of cell proliferation, whereas p38 and JNK are preferentially activated by cellular stress and are implicated in the regulation of survival, apoptosis, differentiation, and contraction, all processes which are important in DA contraction and closure. Sah et al. found that stimulation with EGF causes a biphasic activation of the ERK1/2 MAPK in human ectocervical epithelial cells. The first peak of activation is present at 20 min, and the second is present at 36 h [53] . Kim et al. also reported EGF-induced contraction mediated by the activation of ERK1/2 and regulated by the PI3K pathway, in aortic smooth muscle of DOCA-salt hypertensive rats [52] .
We found that p38-and JNK-specific inhibitors, but not an ERK1/2 inhibitor, can significantly inhibit O 2 -induced DA contraction (Fig. 4c) . Activation of p38 and JNK with anisomycin increased the hypoxic DA tone and subsequently diminished further the O 2 -induced DA contraction (Fig. 4a, b) . Our Western blot data showed that brief O 2 exposure (within 5 min) caused p38 and JNK tyrosine residue phosphorylation in human DASMCs (Fig. 7a, b) . The oxygen-induced phosphorylation of p38 and JNK was completely inhibited by pretreatment with the EGFR inhibitor, AG1478 (Fig. 7c, d ). These observations suggest that p38 and JNK pathway activation, but not ERK pathway activation, are involved in O 2 -induced DA contraction.
p38 MAPK and JNK are involved in HSP27 and caldesmon activation A classic vasoconstriction pathway is one in which signals activate F-actin activation and cause rearrangement of the cytoskeleton. HSP27 and caldesmon are two major modulators involved. Activation of p38 MAPK leads to phosphorylation of HSP27 in many cell types including smooth muscle cells. The functions of HSP27 in smooth muscle are not fully defined, but there is evidence that HSP27 acts as a chaperone or binding partner for Rho and PKC; binds to and modulates interaction of actin, myosin, and tropomyosin; and regulates actin filament structure. HSP27 and caldesmon are widely reported to be involved in cytoskeleton rearrangement and to contribute to calcium sensitization [54] . The latter plays a role in DA contraction [8] [9] [10] . However, there is no reported suggestion that they may be involved in oxygen-induced DA contraction. We detected phosphorylation of HSP27 (at the serine 82 residue) and caldesmon (at tyrosine 27 residues) after 3-5 min of normoxia in cultured human DASMCs (supplemental Fig. 5a, b) . Thus, it appears that both HSP27 and caldesmon are activated by the EGFR/p38/JNK pathway.
Clinical relevance
The merits of ligation versus the use of drugs, such as indomethacin or ibuprofen, to close the PDA in neonates are still debated [55, 56] . However, it is clear that both approaches have significant side effects. Consequently, it would be helpful if a better understanding of the cell signaling that controls the normal closure of the DA leads to improved pharmacological intervention. Similarly, although prostaglandin E 1 has been used to maintain DA patency in infants with congenital heart disease, such as pulmonary atresia, for over 35 years [57, 58] , it too has side effects [59] . Again, better understanding of the physiology may improve treatment.
Conclusions
Oxygen-induced DA contraction is mediated in part by EGFR signal transactivation. This transactivation results in p38 and JNK activation and triggers calcium influx resulting in DA contraction. This finding may offer a new opportunity for the development of improved therapies to close the abnormally patent DA in the neonate or to maintain patency in the presence of critical congenital heart disease to provide pulmonary or systemic blood flow.
Limitation
Although our study suggested that EGFR is likely transactivated by the mitochondrial-derived H 2 O 2 , it remains possible that additional G protein-coupled receptors are also involved.
